Table 2.
Conversations with child's doctor regarding HPV vaccine by HPV vaccine status of adolescent Sonsa
Likely to Vaccinate (N=318) |
|||
---|---|---|---|
Unlikely to Initiate (N=416)% (weighted) | % (weighted) | p-value | |
My child's doctor did a good job explaining what HPV vaccine protects against | |||
Strongly agree/Agree | 34 | 59 | <.0001 |
Disagree/Strongly disagree | 8 | 10 | |
N/A-never discussed HPV vaccine | 58 | 31 | |
My child's doctor knows as much about HPV vaccine as other vaccines | |||
Strongly agree/Agree | 40 | 56 | .0001 |
Disagree/Strongly disagree | 7 | 11 | |
N/A-never discussed HPV vaccine | 53 | 33 | |
My child's doctor and I have spent more time talking about HPV vaccine than other vaccines | |||
Strongly agree/Agree | 13 | 32 | <.0001 |
Disagree/Strongly disagree | 32 | 35 | |
N/A-never discussed HPV vaccine | 55 | 33 |
Groups based on HPV vaccine status of male children age 11–17 years; see Methods section for full definition. The Likely to Vaccinate group includes those likely to initiate HPV vaccination and those who have initiated HPV vaccination who are likely to receive additional doses.